« Yales Scores $140 M Gilead Drug Development Deal | Main | The Thing that Couldn't Die - $55M Drug Development Costs is Back »

03/30/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b014e871e802f970d

Listed below are links to weblogs that reference FDA in NOT Pursuit of Makena Compounders :

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

An in depth interview from Pharmalot of two FDA watchers who say agency now open to criticism for getting involved with pricing issue - where will it end?
http://www.pharmalot.com/2011/03/the-kv-preemie-drug-an-unusual-fda-decision/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada